Traws Pharma, Inc.

Free public records show Traws Pharma, Inc. in 2 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by Traws Pharma, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on Traws Pharma, Inc.

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Stock listing
NASDAQ: TRAW
Type
Medicines

Source: SEC EDGAR, Company filings, CIK 1130598. Retrieved 13 Nov 2026.

Trials over time

Studies Traws Pharma, Inc. leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Traws Pharma, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show Traws Pharma, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Topics

The topics of the markets Traws Pharma, Inc. is in.

All topics

Search all reports for Traws Pharma, Inc. All companies